AG Ventures

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE321D01016
  • NSEID: OCCL
  • BSEID: 506579
INR
111.20
-4.7 (-4.06%)
BSENSE

Dec 05

BSE+NSE Vol: 22.94 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

22.94 k (260.54%) Volume

Shareholding (Sep 2025)

FII

1.26%

Held by 3 FIIs

DII

0.01%

Held by 5 DIIs

Promoter

51.76%

Who are the top shareholders of the Oriental Carbon?

06-Jun-2025

The top shareholders of Oriental Carbon include Cosmopolitan Investments Private Limited with 25.59%, individual investors at 36.39%, and mutual funds holding 2.67%, primarily from HDFC Large and Mid Cap Fund. Foreign Institutional Investors hold a minimal 0.04%, and there are no pledged promoter holdings.

The top shareholders of Oriental Carbon include the promoters, who hold the majority of the shares. The promoter with the highest holding is Cosmopolitan Investments Private Limited, which owns 25.59% of the company. Additionally, individual investors hold a significant portion at 36.39%. <BR><BR>In terms of institutional holdings, two mutual funds collectively hold 2.67%, with HDFC Large and Mid Cap Fund being the highest public shareholder at 2.62%. Foreign Institutional Investors (FIIs) have a minimal presence, holding just 0.04% across three FIIs. There are no pledged promoter holdings reported.

Read More

Who are in the management team of Oriental Carbon?

06-Jun-2025

As of March 2023, the management team of Oriental Carbon includes Arvind Goenka (Managing Director), Akshat Goenka (Joint Managing Director), and several independent directors: S J Khaitan, O P Dubey, K Raghuraman, and Runa Mukherjee, along with Pranab Kumar Maity (Company Secretary) and Sanjay Verma (Nominee from LIC).

As of March 2023, the management team of Oriental Carbon includes the following individuals:<BR><BR>1. Arvind Goenka - Managing Director<BR>2. S J Khaitan - Independent Director<BR>3. O P Dubey - Independent Director<BR>4. K Raghuraman - Independent Director<BR>5. Pranab Kumar Maity - Company Secretary & Compliance Officer<BR>6. Runa Mukherjee - Independent Director<BR>7. Akshat Goenka - Joint Managing Director<BR>8. Sanjay Verma - Nominee (LIC)<BR><BR>These members play various roles in guiding the company's strategic direction and ensuring compliance with regulatory requirements.

Read More

What does Oriental Carbon do?

06-Jun-2025

Oriental Carbon & Chemicals Ltd manufactures Insoluble Sulphur and Sulphuric acid, with a market cap of Rs 210 Cr and reported net sales of 28 Cr and net profit of 1 Cr for the quarter ending March 2025. The company has a P/E ratio of 28.00 and a dividend yield of 3.32%.

Overview:<BR>Oriental Carbon & Chemicals Ltd is a micro-cap company in the commodity chemicals industry, primarily engaged in the manufacturing and sales of Insoluble Sulphur and Sulphuric acid.<BR><BR>History:<BR>The company was incorporated as 'Dharuhera Chemicals Limited' in 1978 and changed its name following the amalgamation with Oriental Carbon in 1984. The latest reported quarter for sales and profit is March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 28 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 1 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 210 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 28.00<BR>- Industry P/E: 47<BR>- Dividend Yield: 3.32%<BR>- Debt Equity: -0.37<BR>- Return on Equity: 2.78%<BR>- Price to Book: 0.79<BR><BR>Contact Details:<BR>Address: Duncan House, 31 Netaji Subhas Road Kolkata West Bengal : 700001<BR>Tel: 91-033-22306831<BR>Email: fin@occlindia.com<BR>Website: http://www.occlindia.com

Read More

Has Oriental Carbon declared dividend?

06-Jun-2025

Yes, Oriental Carbon & Chemicals Ltd has declared a 70% dividend, amounting to ₹7 per share, with an ex-date of July 23, 2024. However, the company has faced significant negative returns across all periods, despite the dividend announcement.

Oriental Carbon & Chemicals Ltd has declared a 70% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 70%<BR>- Amount per share: 7 per share<BR>- Ex-date: 23 Jul 24<BR><BR>Dividend Yield: 3.32%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -17.62%, with a dividend return of 0%, resulting in a total return of -17.62%.<BR><BR>Over the past year, the price return was -67.13%, with a dividend return of 1.00%, leading to a total return of -66.13%.<BR><BR>In the 2-year period, the price return was -73.34%, while the dividend return was 2.59%, culminating in a total return of -70.75%.<BR><BR>For the 3-year period, the price return was -73.22%, with a dividend return of 4.73%, resulting in a total return of -68.49%.<BR><BR>In the last 4 years, the price return was -81.62%, and the dividend return was 4.94%, leading to a total return of -76.68%.<BR><BR>Over the past 5 years, the price return was -68.87%, with a dividend return of 8.03%, resulting in a total return of -60.84%.<BR><BR>Overall, while Oriental Carbon has declared a dividend, the company has experienced significant negative returns across all periods, indicating a challenging financial performance despite the dividend announcement.

Read More

Who are the peers of the Oriental Carbon?

03-Jun-2025

Peers of Oriental Carbon include Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, and others. In terms of management risk, GHCL has excellent management, while Oriental Carbon and others have average risk; India Glycols leads in 1-year returns at 150.27%, whereas Oriental Carbon has the lowest at -67.41%.

Peers: The peers of Oriental Carbon are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Kanchi Karpooram, IVP, ZRZ Bioenergy, and Archit Organosys.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL, while Good management risk is found at Chemplast Sanmar. Average management risk is present in Tata Chemicals, India Glycols, Oriental Carbon, Kanchi Karpooram, and IVP, and the rest. Below Average management risk is seen at Fischer Medical, ZRZ Bioenergy, Archit Organosys, and the rest. Growth is rated as Below Average for Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Oriental Carbon, Kanchi Karpooram, and the rest, while Average growth is noted for Fischer Medical, and Good growth is observed at IVP and Archit Organosys. Capital Structure is rated as Excellent for GHCL, Oriental Carbon, and Kanchi Karpooram, Average for Tata Chemicals and Archit Organosys, and Below Average for Chemplast Sanmar, India Glycols, IVP, ZRZ Bioenergy, and Fischer Medical.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 150.27%, while Oriental Carbon has the lowest at -67.41%. This indicates that Oriental Carbon's 1-year return is significantly lower than its peers. Additionally, the six-month return is negative for Tata Chemicals, Chemplast Sanmar, Kanchi Karpooram, IVP, and Polychem.

Read More

What is the technical trend for Oriental Carbon?

09-Jun-2025

As of May 12, 2025, Oriental Carbon's technical trend is mildly bearish, influenced by mixed signals from MACD, moving averages, and Bollinger Bands across different time frames.

As of 12 May 2025, the technical trend for Oriental Carbon has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, indicating some positive momentum, while the monthly MACD remains bearish, suggesting longer-term weakness. The daily moving averages are mildly bearish, reinforcing the cautious stance. Bollinger Bands show a bullish signal on the weekly chart but are mildly bearish on the monthly, indicating mixed signals across time frames. The KST is mildly bullish weekly but bearish monthly, further complicating the outlook. Overall, the current technical stance is mildly bearish, driven primarily by the bearish monthly indicators and the mildly bearish daily moving averages.

Read More

How big is Oriental Carbon?

24-Jul-2025

As of 24th July, Oriental Carbon & Chemicals Ltd has a market capitalization of 223.00 Cr, with recent net sales of 108.27 Cr and a net profit of 10.47 Cr. Shareholder's funds are valued at 266.34 Cr, and total assets amount to 326.66 Cr.

As of 24th July, Oriental Carbon & Chemicals Ltd has a market capitalization of 223.00 Cr, which classifies it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 108.27 Cr and a Net Profit of 10.47 Cr.<BR><BR>For the latest annual period, the Shareholder's Funds were valued at 266.34 Cr, while the Total Assets amounted to 326.66 Cr.

Read More

When is the next results date for Oriental Carbon?

29-Jul-2025

The next results date for Oriental Carbon is August 4, 2025.

The next results date for Oriental Carbon is scheduled for August 4, 2025.

Read More

How has been the historical performance of AG Ventures?

13-Nov-2025

AG Ventures has experienced significant financial declines, with net sales and total operating income dropping from 535.86 Cr in Mar'23 to 108.28 Cr in Mar'25, alongside reduced profits and cash flow, indicating a challenging financial landscape. Total assets and liabilities also decreased substantially during this period.

Answer:<BR>The historical performance of AG Ventures shows significant fluctuations in its financial metrics over the years.<BR><BR>Breakdown:<BR>AG Ventures experienced a notable decline in net sales, dropping from 535.86 Cr in Mar'23 to 108.28 Cr in Mar'25, with a peak in Mar'23. Total operating income followed a similar trend, decreasing from 535.86 Cr in Mar'23 to 108.28 Cr in Mar'25. The total expenditure also saw a decline, from 426.20 Cr in Mar'23 to 95.16 Cr in Mar'25. Operating profit (PBDIT) decreased sharply from 112.80 Cr in Mar'23 to 15.60 Cr in Mar'25, reflecting a declining operating profit margin which fell from 20.46% in Mar'23 to 12.12% in Mar'25. Profit before tax also showed a downward trend, from 70.39 Cr in Mar'23 to 10.97 Cr in Mar'25, while profit after tax decreased from 53.59 Cr in Mar'23 to 5.62 Cr in Mar'25. The consolidated net profit followed suit, declining from 48.64 Cr in Mar'23 to 10.47 Cr in Mar'25. On the balance sheet, total assets decreased from 895.63 Cr in Mar'24 to 326.66 Cr in Mar'25, and total liabilities also fell from 895.63 Cr to 326.66 Cr in the same period. Cash flow from operating activities dropped significantly from 105.00 Cr in Mar'23 to 8.00 Cr in Mar'25, indicating a tightening cash position. Overall, AG Ventures has faced a challenging financial landscape with declining revenues and profits over the past few years.

Read More

Are AG Ventures latest results good or bad?

13-Nov-2025

AG Ventures' latest results are concerning, showing a 43.30% increase in net sales but a 93.69% drop in net profit, alongside a significant decline in operating margins. Overall, the company's performance indicates serious operational challenges and a negative outlook.

AG Ventures' latest results indicate a challenging situation for the company. While there was a notable sequential increase in net sales, which rose by 43.30% quarter-on-quarter to ₹29.95 crores, this growth was overshadowed by a significant decline in profitability. The consolidated net profit dropped to ₹0.20 crores, reflecting a staggering 93.69% decrease compared to the previous quarter, and remained flat year-on-year.<BR><BR>The operating margin also fell sharply to 5.28%, the lowest in eight quarters, down from 13.11% in the previous quarter and 15.66% a year ago. This indicates a serious erosion of profitability, suggesting that the company is facing significant operational challenges, including pricing pressures and rising costs.<BR><BR>Additionally, the stock has performed poorly, declining 35.85% over the past year and 80.34% over the last two years, indicating a lack of investor confidence and persistent underperformance relative to market benchmarks.<BR><BR>Overall, while there are some signs of revenue recovery, the substantial drop in profitability and operating margins points to a negative outlook for AG Ventures, making the latest results more bad than good.

Read More

Should I buy, sell or hold AG Ventures?

14-Nov-2025

Is AG Ventures overvalued or undervalued?

14-Nov-2025

As of November 13, 2025, AG Ventures is overvalued with a PE ratio of 25.58, an EV to EBITDA ratio of 11.85, and a low Price to Book Value of 0.58, alongside a poor ROE of 2.27% and a year-to-date return of -30.06%, indicating a significant underperformance compared to its peers and the Sensex.

As of 13 November 2025, AG Ventures has moved from an expensive to a very expensive valuation grade. The company is currently overvalued based on its financial ratios and peer comparisons. The PE ratio stands at 25.58, while the EV to EBITDA ratio is 11.85, and the Price to Book Value is notably low at 0.58. <BR><BR>In comparison to peers, AG Ventures' PE ratio is significantly lower than that of Solar Industries at 94.31 and Gujarat Fluoroch at 58.25, both of which are also classified as very expensive. The company's return on equity (ROE) is just 2.27%, indicating poor profitability relative to its equity. Furthermore, AG Ventures has underperformed the Sensex significantly over various time frames, with a year-to-date return of -30.06% compared to the Sensex's 8.11%. This combination of high valuation metrics and poor performance suggests that AG Ventures is overvalued in the current market.

Read More

Why is AG Ventures falling/rising?

04-Dec-2025

As of 04-Dec, AG Ventures Ltd's stock price is at Rs. 115.90, reflecting a 3.98% decline and a new 52-week low. The stock has dropped 12.06% over the past five days and 28.06% in the last month, significantly underperforming compared to the Sensex.

As of 04-Dec, AG Ventures Ltd's stock price is falling, currently at Rs. 115.90, which reflects a decrease of Rs. 4.8 or 3.98%. This decline is part of a broader trend, as the stock has been losing value for the past five days, resulting in a total drop of 12.06% during this period. Additionally, the stock has reached a new 52-week low today, indicating significant downward pressure.<BR><BR>The performance of AG Ventures is notably poor compared to the benchmark Sensex, which has shown a slight increase of 0.53% over the same week. Over the past month, AG Ventures has experienced a substantial decline of 28.06%, while the Sensex has gained 2.16%. Year-to-date, the stock has fallen by 48.11%, contrasting sharply with the Sensex's 9.12% increase. This trend continues over longer periods, with the stock down 53.51% over the past year and a staggering 86.94% over the last five years, while the Sensex has risen by 89.14% in that time.<BR><BR>The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent bearish trend. Furthermore, the day's low of Rs. 115, which represents a 4.72% drop from the previous close, reinforces the stock's downward trajectory. Although there has been a rise in investor participation, as evidenced by a 25.21% increase in delivery volume compared to the 5-day average, this has not translated into price stability or growth.<BR><BR>Overall, the combination of consistent declines, poor relative performance against the benchmark, and the establishment of a new 52-week low are key factors contributing to the falling stock price of AG Ventures Ltd.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 6.93%

  • The company has been able to generate a Return on Equity (avg) of 6.93% signifying low profitability per unit of shareholders funds
2

Poor long term growth as Net Sales has grown by an annual rate of -19.70% and Operating profit at -37.29% over the last 5 years

 
3

Negative results in Sep 25

4

With ROE of 2.3, it has a Very Expensive valuation with a 0.4 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 111 Cr (Micro Cap)

stock-summary
P/E

19.00

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.11

stock-summary
Return on Equity

2.27%

stock-summary
Price to Book

0.43

Revenue and Profits:
Net Sales:
30 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-34.78%
0%
-34.78%
6 Months
-47.25%
0%
-47.25%
1 Year
-55.1%
0%
-55.1%
2 Years
-85.29%
0.89%
-84.4%
3 Years
-86.18%
2.68%
-83.5%
4 Years
-88.34%
3.79%
-84.55%
5 Years
-87.47%
6.32%
-81.15%

Latest dividend: 7 per share ex-dividend date: Jul-23-2024

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
Announcements stock-summary

Outcome Of Board Meeting Dated 12.11.2025

12-Nov-2025 | Source : BSE

Outcome of Board Meeting dated 12.11.2025

Board Meeting Outcome for Outcome Of The Board Meeting Held On November 12 2025

12-Nov-2025 | Source : BSE

This is further to our letter dated November 04 2025 intimating the date of the Board Meeting for the approval of Un-audited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30 2025. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we would like to inform you that the Board today has approved the Un-audited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30 2025. We attach herewith a copy of the approved Un-audited (Standalone and Consolidated) Financial Results along with the Limited Review Report of the auditors.

Announcement under Regulation 30 (LODR)-Change in Directorate

06-Nov-2025 | Source : BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 including amendments thereunder (Listing Regulations) this is to inform you that as per the internal guidelines and policy of Life Insurance Corporation of India (LIC) Mr. Sanjay Verma (DIN: 09784146) has completed his tenure of 3 years as prescribed by LIC and consequently he ceased to be the Nominee Director of the Company w.e.f. the closure of business hours on November 06 2025.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

AG Ventures Ltd has declared 70% dividend, ex-date: 23 Jul 24

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-19.70%
EBIT Growth (5y)
-37.29%
EBIT to Interest (avg)
10.65
Debt to EBITDA (avg)
1.42
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.47
Tax Ratio
2.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.35%
ROCE (avg)
9.36%
ROE (avg)
6.93%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
40
Price to Book Value
0.43
EV to EBIT
13.34
EV to EBITDA
8.11
EV to Capital Employed
0.36
EV to Sales
0.80
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.72%
ROE (Latest)
2.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (2.67%)

FIIs

Held by 3 FIIs (1.26%)

Promoter with highest holding

Cosmopolitan Investments Private Limited (25.59%)

Highest Public shareholder

Hdfc Large And Mid Cap Fund (2.62%)

Individual Investors Holdings

36.1%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -6.73% vs 60.15% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 0.00% vs -98.01% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29.95",
          "val2": "32.11",
          "chgp": "-6.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.58",
          "val2": "5.03",
          "chgp": "-68.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.19",
          "val2": "0.10",
          "chgp": "90.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.28%",
          "val2": "15.66%",
          "chgp": "-10.38%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 0.12% vs 29.01% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -56.46% vs -70.78% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50.85",
          "val2": "50.79",
          "chgp": "0.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.33",
          "val2": "6.69",
          "chgp": "-35.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.11",
          "chgp": "136.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "7.46",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.37",
          "val2": "7.74",
          "chgp": "-56.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.52%",
          "val2": "13.17%",
          "chgp": "-4.65%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 39.73% vs -86.08% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -71.18% vs -7.56% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "80.44",
          "val2": "57.57",
          "chgp": "39.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.54",
          "val2": "12.50",
          "chgp": "-15.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.23",
          "val2": "0.09",
          "chgp": "155.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.46",
          "val2": "26.90",
          "chgp": "-72.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.59",
          "val2": "33.28",
          "chgp": "-71.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.10%",
          "val2": "21.71%",
          "chgp": "-8.61%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 33.40% vs -84.85% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -78.84% vs 1.73% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "108.28",
          "val2": "81.17",
          "chgp": "33.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.12",
          "val2": "18.57",
          "chgp": "-29.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.73",
          "val2": "0.11",
          "chgp": "563.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.46",
          "val2": "38.47",
          "chgp": "-80.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.47",
          "val2": "49.48",
          "chgp": "-78.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.12%",
          "val2": "22.88%",
          "chgp": "-10.76%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary
Sep'25
Sep'24
Change(%)
Net Sales
29.95
32.11
-6.73%
Operating Profit (PBDIT) excl Other Income
1.58
5.03
-68.59%
Interest
0.19
0.10
90.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.20
0.20
Operating Profit Margin (Excl OI)
5.28%
15.66%
-10.38%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is -6.73% vs 60.15% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 0.00% vs -98.01% in Sep 2024

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
50.85
50.79
0.12%
Operating Profit (PBDIT) excl Other Income
4.33
6.69
-35.28%
Interest
0.26
0.11
136.36%
Exceptional Items
0.00
7.46
-100.00%
Consolidate Net Profit
3.37
7.74
-56.46%
Operating Profit Margin (Excl OI)
8.52%
13.17%
-4.65%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 0.12% vs 29.01% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -56.46% vs -70.78% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
80.44
57.57
39.73%
Operating Profit (PBDIT) excl Other Income
10.54
12.50
-15.68%
Interest
0.23
0.09
155.56%
Exceptional Items
7.46
26.90
-72.27%
Consolidate Net Profit
9.59
33.28
-71.18%
Operating Profit Margin (Excl OI)
13.10%
21.71%
-8.61%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 39.73% vs -86.08% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -71.18% vs -7.56% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
108.28
81.17
33.40%
Operating Profit (PBDIT) excl Other Income
13.12
18.57
-29.35%
Interest
0.73
0.11
563.64%
Exceptional Items
7.46
38.47
-80.61%
Consolidate Net Profit
10.47
49.48
-78.84%
Operating Profit Margin (Excl OI)
12.12%
22.88%
-10.76%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 33.40% vs -84.85% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -78.84% vs 1.73% in Mar 2024

stock-summaryCompany CV
About AG Ventures Ltd stock-summary
stock-summary
AG Ventures Ltd
Micro Cap
Commodity Chemicals
Oriental Carbon & Chemicals Limited (OCCL) was formerly incorporated as 'Dharuhera Chemicals Limited' on June 19, 1978. The Company acquired its present name after the amalgamation of Oriental Carbon with itself in 1984. The Company's core business is manufacturing and sales of Insoluble Sulphur, Sulphuric acid. The Company is a global supplier of Insoluble Sulphur of which major turnover is from Exports. It has 2 manufacturing facilities, one in Haryana and other one in Gujarat.
Company Coordinates stock-summary
Company Details
Duncan House, 31 Netaji Subhas Road Kolkata West Bengal : 700001
stock-summary
Tel: 91-033-22306831
stock-summary
fin@occlindia.com
Registrar Details
Link Intime India Pvt Ltd, 59 C , Chowringhee Road, 3rd Floor, Kolkata